Literature DB >> 28531893

Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain.

Clement C Zai1, Arun K Tiwari, Nabilah I Chowdhury, Eva J Brandl, Sajid A Shaikh, Natalie Freeman, Jeffrey A Lieberman, Herbert Y Meltzer, James L Kennedy, Daniel J Müller.   

Abstract

BACKGROUND: Schizophrenia (SCZ) is a chronic severe neuropsychiatric disorder, where pharmacological treatment has been hindered by adverse effects, including antipsychotic-induced weight gain (AIWG) and related complications. Genetic studies have been exploring the appetite regulation and energy homeostasis pathways in AIWG with some promising leads. The serotonin system has been shown to participate in these pathways.
METHODS: In the current study, we examined single nucleotide polymorphisms across the serotonin receptor genes HTR3A and HTR3B. Prospective weight change was assessed for a total of 149 SCZ patients of European ancestry.
RESULTS: We did not find the tested HTR3A or HTR3B gene markers to be associated with AIWG in our sample.
CONCLUSION: Our preliminary findings suggest that these receptors may not play a major role in predicting AIWG.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Antipsychotic-induced weight gain; Pharmacogenetics; Schizophrenia; Serotonin 3A and 3B receptor genes (HTR3A, HTR3B)

Mesh:

Substances:

Year:  2017        PMID: 28531893      PMCID: PMC5653224          DOI: 10.1159/000457903

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  33 in total

1.  Good diagnoses require good diagnosticians: collecting and integrating the data.

Authors:  J Endicott
Journal:  Am J Med Genet       Date:  2001-01-08

2.  Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: common and specific effects of key regulators of fat-mass homoeostasis genes.

Authors:  Elia Creta; Chiara Fabbri; Alessandro Serretti
Journal:  Pharmacogenet Genomics       Date:  2015-07       Impact factor: 2.089

3.  CCK and 5-HT act synergistically to suppress food intake through simultaneous activation of CCK-1 and 5-HT3 receptors.

Authors:  Matthew R Hayes; Mihai Covasa
Journal:  Peptides       Date:  2005-04-19       Impact factor: 3.750

4.  Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.

Authors:  M Masellis; V Basile; H Y Meltzer; J A Lieberman; S Sevy; F M Macciardi; P Cola; A Howard; F Badri; M M Nöthen; W Kalow; J L Kennedy
Journal:  Neuropsychopharmacology       Date:  1998-08       Impact factor: 7.853

5.  Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data.

Authors:  Frank Dudbridge
Journal:  Hum Hered       Date:  2008-03-31       Impact factor: 0.444

6.  Treatment with the 5-HT3 antagonist tropisetron modulates glucose-induced obesity in mice.

Authors:  S Weber; V Volynets; G Kanuri; I Bergheim; S C Bischoff
Journal:  Int J Obes (Lond)       Date:  2009-12       Impact factor: 5.095

7.  Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.

Authors:  G Rammes; B Eisensamer; U Ferrari; M Shapa; G Gimpl; K Gilling; C Parsons; K Riering; G Hapfelmeier; B Bondy; W Zieglgänsberger; F Holsboer; R Rupprecht
Journal:  Mol Psychiatry       Date:  2004-09       Impact factor: 15.992

8.  Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.

Authors:  Anil K Malhotra; Christoph U Correll; Nabilah I Chowdhury; Daniel J Müller; Peter K Gregersen; Annette T Lee; Arun K Tiwari; John M Kane; W Wolfgang Fleischhacker; Rene S Kahn; Roel A Ophoff; Herbert Y Meltzer; Todd Lencz; James L Kennedy
Journal:  Arch Gen Psychiatry       Date:  2012-09

9.  Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.

Authors:  E L Nurmi; S L Spilman; F Whelan; L L Scahill; M G Aman; C J McDougle; L E Arnold; B Handen; C Johnson; D G Sukhodolsky; D J Posey; L Lecavalier; K A Stigler; L Ritz; E Tierney; B Vitiello; J T McCracken
Journal:  Transl Psychiatry       Date:  2013-06-25       Impact factor: 6.222

10.  Regulation of systemic energy homeostasis by serotonin in adipose tissues.

Authors:  Chang-Myung Oh; Jun Namkung; Younghoon Go; Ko Eun Shong; Kyuho Kim; Hyeongseok Kim; Bo-Yoon Park; Ho Won Lee; Yong Hyun Jeon; Junghan Song; Minho Shong; Vijay K Yadav; Gerard Karsenty; Shingo Kajimura; In-Kyu Lee; Sangkyu Park; Hail Kim
Journal:  Nat Commun       Date:  2015-04-13       Impact factor: 14.919

View more
  3 in total

Review 1.  Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications.

Authors:  Kazunari Yoshida; Daniel J Müller
Journal:  Mol Neuropsychiatry       Date:  2018-09-26

2.  Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia.

Authors:  Zachary Freyberg; Despoina Aslanoglou; Ripal Shah; Jacob S Ballon
Journal:  Front Neurosci       Date:  2017-07-28       Impact factor: 4.677

3.  Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia.

Authors:  Diana Z Paderina; Anastasiia S Boiko; Ivan V Pozhidaev; Anna V Bocharova; Irina A Mednova; Olga Yu Fedorenko; Elena G Kornetova; Anton J M Loonen; Arkadiy V Semke; Nikolay A Bokhan; Svetlana A Ivanova
Journal:  J Pers Med       Date:  2021-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.